Preview

In Vitro Diagnostics (IVD) Market - Forecast, 2012 - 2020 by True Market Research

Good Essays
Open Document
Open Document
812 Words
Grammar
Grammar
Plagiarism
Plagiarism
Writing
Writing
Score
Score
In Vitro Diagnostics (IVD) Market - Forecast, 2012 - 2020 by True Market Research
In Vitro Diagnostics (IVD) Market - Forecast, 2012 - 2020 by True Market Research.com

In Vitro Diagnostics (IVD) provide critical information about the physiological and pathological state of body for effective health and drug/therapy monitoring. In 2011, North America and Europe occupied majority share of the in vitro diagnostics market due to the high healthcare expenditure and structured association of clinical laboratories. On the other hand, market players in the in vitro diagnostics market are keen to accelerate their growth by capitalizing on unmet opportunities present in the emerging economies. Although clinical chemistry IVDs led the market in 2011 across the US, India, and China market, the growth in the molecular diagnostics segment is forecasted owing to their efficacy in the early detection of the disease.

Increasing ageing population and rising cases of infectious diseases and chronic diseases – such as cardiovascular diseases, diabetes, cancer, and sexually transmitted diseases – are significant growth drivers of this market. Besides this, escalating health expenditure and increasing demand for advanced and automated diagnostics technologies are likely to drive the in vitro diagnostics market. However, on the other hand, reimbursement issues and the existence of ambiguity in the regulatory environment are restraints for this market. Despite this, the emerging molecular diagnostics and epigenomics-based diagnostics segments are expected to provide considerable growth opportunities in this market. Even, collaborations among diagnostic and pharmaceutical companies for research and development will help this market grow in the near future.

The global in vitro diagnostics market is segmented into markets by technique, product type, application, end users, and geography. The global in vitro diagnostics market by technique is segmented as immunoassay/immunochemistry, clinical chemistry, hematology, coagulation, microbiology, molecular diagnostics

You May Also Find These Documents Helpful

  • Satisfactory Essays

    ELISA testing

    • 393 Words
    • 2 Pages

    8. The ELISA test can also be used to detect antibodies that are produced in response to a specific antigen. Using information about how you completed this ELISA experiment, outline a procedure for testing for antibodies in the blood.…

    • 393 Words
    • 2 Pages
    Satisfactory Essays
  • Good Essays

    Introduction:Management in clinical diagnostic fields are frequently involved in cost analysis of new procedures due to the constantly changing science and technology. Also due to the health care organization especially the diagnostic division being tightly regulated by accreditation and regulatory bodies bringing a new procedure in-house requires in depth analysis prior to an any decision being taken.…

    • 1892 Words
    • 7 Pages
    Good Essays
  • Good Essays

    Early diagnosis can also transform the design and execution of clinical trials to test new treatments.…

    • 1221 Words
    • 4 Pages
    Good Essays
  • Better Essays

    wouldn’t need to order as many tests if they knew the results of previous ones, and early studies led to very promising projections of costly tests…

    • 2308 Words
    • 10 Pages
    Better Essays
  • Good Essays

    Due to increasing competition in the field of medical testing it has become prudent for Laboratorio De Analisis Argentina (LAA) to evaluate its process and identify strengths and weaknesses to improve the operations of their laboratories. An in-depth investigation into day-to-day, step-by-step breakdown of activities has uncovered where, and how LAA can achieve efficient operations.…

    • 1434 Words
    • 6 Pages
    Good Essays
  • Satisfactory Essays

    The explosion of whole genome sequencing method anticipate personalized cancer treatment through development of high end sequencing methods along with exponential decline in the cost of sequencing. A significant decline in the cost of whole genome sequencing is likely to generate a potential market of US$5.2 Billion in 2013. The potential for whole genome sequencing help the market players to gauge maximum opportunity for growth.…

    • 304 Words
    • 1 Page
    Satisfactory Essays
  • Powerful Essays

    Next Generation Sequencing (NGS) Market [Platforms (Illumina HiSeq, MiSeq, Life Technologies Ion Proton/PGM, 454 Roche), Bioinformatics (RNA-Seq, ChIP-Seq), (Pyrosequencing, SBS, SMRT), (Diagnostics, Personalized Medicine)] Global Forecast to 2017…

    • 2600 Words
    • 16 Pages
    Powerful Essays
  • Powerful Essays

    High Throughput Screening (HTS) Market research report emphasizes on both the technology and product segments of HTS in biotechnology and pharmaceutical application areas. The major technologies analyzed include Ultra High Throughput Screening, High Content Screening, Bioinformatics and Microfluidics/Lab-On-a-Chip; and the major product segments encompass HTS Services and HTS Tools. The global markets for Novel High Throughput Screening Products and Cell Based Assays are also discussed in the report. Markets covered for Microfluidics and Bioinformatics pertain to the applications of HTS. The report provides essential information including market data, segmentation, market size, key trends, M&A, product developments, industry forecasts, corporate intelligence, and other relevant information. The report lists more than 600 companies that are engaged in HTS services and/or production of HTS tools/instruments. Major Contract Research Organizations serving HTS industry are also covered in the corporate directory section of this report. Estimations and predictions are graphically represented by region, by technology and by product segment. Compilation of Worldwide Patents and Research related to High Throughput Screening is also provided. A global perspective is presented along with regional analysis covering the regions of North America, Europe, Asia-Pacific and Rest of World. The market is analyzed in US Dollars and includes 112 exclusive exhibits. High throughput screening market size, market review, market shares, and other key market results and trends are analyzed.…

    • 5659 Words
    • 26 Pages
    Powerful Essays
  • Good Essays

    There are high cost and risks associated with developing new drugs and bringing it to market as out of every 5000 compounds tested in the laboratory by a drug company, only one of these ultimately make it to the market.…

    • 616 Words
    • 3 Pages
    Good Essays
  • Best Essays

    The report focuses on "In Vitro Diagnostic (IVD) Market [Instruments, Reagents & Data Management Systems] [Technique (Immunoassay, Clinical Chemistry, Molecular Diagnostics, Hematology) & Applications (Diabetes, Infectious Diseases, Cancer & Cardiology)] Systems, End Users] Forecast To 2017"…

    • 2070 Words
    • 13 Pages
    Best Essays
  • Satisfactory Essays

    The digital pathology market is segmented into components, end users and geography. The products market consists of the Whole slide imaging (WSI), Image analysis- informatics and Storage, communication and integrated platforms. The WSI is the highest revenue generating market…

    • 484 Words
    • 2 Pages
    Satisfactory Essays
  • Satisfactory Essays

    The global cell analysis market is a technology-driven market and is marked by the Threat of Obsolescence, wherein technologies as well as their adoption by end users changes very rapidly. Hospitals, academic and government institutes, as well as pharmaceutical and biotechnology companies are increasing their focus on using cell analysis as a powerful research tool in research, drug discovery, and diagnosis. The cell analysis instruments market is the fastest-growing segment in the cell analysis market. In cell analysis, the accuracy of the results obtained depends on the quality of consumables, instruments, and data management software. In the recent years, advanced cell image analysis and data management solutions have been introduced, but there is scope for further improvement of these solutions. Many of the key players in the cell analysis instruments market are collaborating with companies and academic institutes in order to offer products with better software. For instance, in February 2014, Agilent Technologies (U.S.) collaborated with Cell Line Genetics (U.S.) for high throughput screening of cell line characterization services for regenerative medicine. Cell Line Genetics will develop high throughput, genomic characterizations to confirm and monitor the integrity of a cell line for translational and regenerative medicine research by using Agilents technologies.…

    • 414 Words
    • 3 Pages
    Satisfactory Essays
  • Satisfactory Essays

    This market research report package offers a perspective on the actual market situation, trends and future outlook for electro-diagnostic equipment in different countries around the world. The studies provide essential market information for decision-makers including:…

    • 285 Words
    • 2 Pages
    Satisfactory Essays
  • Satisfactory Essays

    cusabio

    • 624 Words
    • 3 Pages

    CUSABIO is a leading biotechnology company specialized in production of high quality products for gene, protein, antibody, ELISA kit, raw material for production of diagnostic kit, drug residues, food safety small molecules & other small molecules. Our products cover research areas such as the biosynthesis/metabolism, neurobiology, cytokine, growth factor, autoimmunity and so on, including over 10000 kinds of ELISA kits for 37 species; over 6000 antibodies, thousands of high-quality recombinant proteins through the prokaryotic and eukaryotic expression systems; small molecule antigens and standards used in drug residues, food safety and other field and dozens of excellent proteins and antibodies for diagnostic use.…

    • 624 Words
    • 3 Pages
    Satisfactory Essays
  • Powerful Essays

    Biosimilar market in APAC

    • 1847 Words
    • 8 Pages

    The demand for biologic drugs is increasing worldwide due to the rising abilities of science to reveal the underlying disease mechanisms and to design recombinant protein drugs based on this knowledge. However, innovator biologic drugs are extremely expensive, which limit their availability and affordability in emerging markets. Biosimilars offer hope in reducing the healthcare costs to a large extent. The governments in the emerging markets tend to approach biosimilar sector as a healthcare solution rather than a regulatory issue. They are developing regulatory framework in their countries around these products targeting mainly to improve access to these products. Many are promoting local players to invest in biosimilar development by offering various incentives. The fact that many of these countries do not have a stringent regulatory framework has helped in lowering the entry barriers for the local players.…

    • 1847 Words
    • 8 Pages
    Powerful Essays